Phamily Pharma SRL

Dissolution judiciaire ou nullité

Phamily Pharma reported total assets of 409,856 € at the end of the 2022 financial year (annual accounts filed with the NBB on 30 Sep 2023).

Company number (CBE) 0865.835.955 · VAT BE0865835955
9300 Aalst
active in Retail sale of pharmaceutical products (NACE 47730)
operating since 17 Jun 2004 (≈ 22 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Phamily Pharma shows with a free account.

See the score
Profile
SRL since 2004
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2022

Net result−81,087 €
Equity−19,222 €
Cash3,939 €
EBITDA−52,410 €
Total assets409,856 €
The line marks its sector median: 44.2% (2068 companies).

Change 2019 → 2022: Total assets +9 %

Accounts of the company itself (not consolidated).

The full file covers 7 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Phamily Pharma's annual accounts

20222021202020192018
Net result−81,087 €
Equity−19,222 €
Cash3,939 €
EBITDA−52,410 €
Total assets409,856 €

Filed annual accounts

  • Year ended 31 Dec 2022filed on 30 Sep 2023
  • Year ended 31 Dec 2021filed on 26 Oct 2022
  • Year ended 31 Dec 2020filed on 26 Oct 2022
  • Year ended 31 Dec 2019filed on 26 Oct 2022
  • Year ended 31 Dec 2018filed on 30 Aug 2019

Phamily Pharma's financial analysis

Management and control of Phamily Pharma

2 active director(s) in the register.

Phamily Pharma's shareholders and holdings →

Phamily Pharma's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0865.835.955
VAT number
BE0865835955
Peppol
Not found on Peppol as of 10 Nov 2026 · Check
Legal form
SRL
Incorporated
17 Jun 2004
Registered office
9300 Aalst
Latest accounts
2022 · filed on 30 Sep 2023
Activity
Retail sale of pharmaceutical products (NACE 47730)

Phamily Pharma (SRL) has been based in Aalst since 2004, active in: retail sale of pharmaceutical products. For 2022, it reports a net loss of 81,087 € and equity of −19,222 €; its revenue is not published. Its solvency stands at -4.7%, below the median of its sector (44.2%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Phamily Pharma

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Phamily Pharma

What is the revenue of Phamily Pharma?

Phamily Pharma files its accounts in a format where revenue is optional: it is not published for 2022.

What is the VAT number of Phamily Pharma?

In Belgium, the VAT number is the company number prefixed with BE: BE0865835955 for Phamily Pharma, if the company is VAT-registered. Its company number (CBE) is 0865.835.955.

Where is the registered office of Phamily Pharma?

According to the CBE register, the registered office of Phamily Pharma is in 9300 Aalst.

What is the equity of Phamily Pharma?

At the close of the 2022 financial year, the equity of Phamily Pharma amounts to -19,222 €, a solvency of -4.7% of total assets.

Who manages Phamily Pharma?

The register lists 2 active mandates at Phamily Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Phamily Pharma

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 01 Sep 2026

No credit card, no commitment.

What each plan unlocks →